3841. Byetta-PSUSA-00009147-202003 3842. Velcade-H-C-PSUSA-00000424-202004 3843. Bortezomib Sun-H-C-PSUSA-00000424-202004: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3844. Nimenrix-H-C-PSUSA-00010044-202004 3845. Vipdomet-H-C-PSUSA-00010061-202004: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation 3846. Omnitrope-H-C-PSUSA-00002772-202003 3847. NutropinAq-H-C-PSUSA-00002772-202003 3848. Bortezomib Accord-H-C-PSUSA-00000424-202004 3849. Bortezomib Hospira-H-C-PSUSA-00000424-202004 3850. Bortezomib Fresenius Kabi-H-C-PSUSA-00000424-202004 3851. Lysodren-H-C-521-PSUSA-00002075-202004 3852. Repatha-H-C-PSUSA-00010405-202007 3853. Dacogen-H-C-PSUSA-00009118-202005 3854. Tegsedi-PSUSA-00010697-202007 3855. Opdivo-H-C-PSUSA-00010379-202007 3856. Fycompa-H-C-PSUSA-00009255-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3857. Kyprolis-H-C-PSUSA-00010448-202007: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3858. Eliquis-H-C-PSUSA-00000226-202005 3859. Buvidal-H-C-PSUSA-00000459-202007 3860. Ibrance-H-C-PSUSA-00010544-202008 3861. SonoVue-H-C-PSUSA-00002822-202009 3862. Blitzima-H-C-PSUSA-00002652-202011 3863. Rubraca-H-C-PSUSA-00010694-202012 3864. Riximyo-H-C-PSUSA-00002652-202011 3865. Veklury-H-C-PSUSA-00010840-202011: EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation 3866. SomaKit TOC-H-C-PSUSA-00010552-202012 3867. Givlaari-PSUSA-00010839-202011 3868. Revlimid-H-C-PSUSA-00001838-202012 3869. Lenalidomide Accord-H-C-PSUSA-00001838-202012 3870. Luxturna-H-C-PSUSA-00010742-202101